(British Society of Gastroenterology)
- Stomach microbiota in gastric cancer development and clinical implications
- Proton pump inhibitors and the risk of inflammatory bowel disease: a Mendelian randomisation study
- Animal experiments of a new through-the-scope full-thickness endoscopic suturing device
- Author reply to: Exploring the impact of short-acting GLP-1 receptor agonists on GERD risk
- Prevalence of steatotic liver disease, advanced fibrosis and cirrhosis among community-dwelling overweight and obese individuals in the USA
- Predicting treatment response in ASUC: do we measure systemic severity, organ response or both?
- Is mailed outreach and patient navigation a perfect solution to improve HCC screening?
- Microscopic pathology assessment of colorectal polyp size is less accurate than intracolonoscopic assessment
- Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma
- Age-related patterns of microbial dysbiosis in multiplex inflammatory bowel disease families
- Cholesterols new tricks propel MASH-HCC: impact in immunotherapy
- Response to: short-chain fatty acids in patients with severe acute pancreatitis: friend or foe?
- MED12 loss activates endogenous retroelements to sensitise immunotherapy in pancreatic cancer
- CD64+ fibroblast-targeted vilanterol and a STING agonist augment CLDN18.2 BiTEs efficacy against pancreatic cancer by reducing desmoplasia and enriching stem-like CD8+ T cells
- Immunomodulation and entry inhibition: selgantolimods double punch against hepatitis B virus
Esprimi il gradimento a questo contenuto
[Totale voti: 0 Media: 0]
